Juan M. Hincapie-Castillo/LinkedIn
Feb 28, 2026, 03:58
Juan M. Hincapie-Castillo: FDA Releases Draft 2026 Guidance Plans Including Endometriosis-Associated Pain
Juan M. Hincapie-Castillo, Associate Professor at University of Pittsburgh, shared a post on LinkedIn:
“The FDA Center for Drug Evaluation and Research released its New and Revised Draft Guidances Planned for Publication in CY 2026.
A few that stand out to me working in RWE, drug safety, and pain:
- Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
- Considerations for the Inclusion of Older Adults in Clinical Trials
- Endometriosis-Associated Pain: Establishing Effectiveness and Safety of Drugs for Management
- Sickle Cell Disease: Endpoints for the Development of Products for Prevention and Treatment of SCD Complications
- Development of a Shared System or Separate REMS.”
Proceed to the pages attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 18:44Multidisciplinary Guidance Needed for Informed Reproductive Choices – ESHRE
-
Apr 17, 2026, 18:37ART Professionals Invited to Contribute to Updated ESHRE-ALPHA KPI Consensus – ESHRE
-
Apr 17, 2026, 18:31Yannick Hurni: What Is a ‘Normal Uterus’? From Morphology to Function
-
Apr 17, 2026, 18:28Narrative Review Reassesses Luteinizing Hormone Activity in ART – RBMO
-
Apr 17, 2026, 18:20ASRM Celebrates Member Contributions With Sigal Klipstein Spotlight – ASRM
-
Apr 17, 2026, 14:24Rare Cases of Endometriosis in Men – Meliodays Medical
-
Apr 17, 2026, 14:18Hesam Ghafouri Kalajahi: Functional Heterogeneity of Endometriomas in FSH Responsiveness
-
Apr 17, 2026, 14:14Join Us on ASRM/CFAS Business of Medicine Conference 2026 in Chicago – ASRM
-
Apr 17, 2026, 14:12A Call for Reproductive Health Issues to Feature in 2027 Campaign – Collectif BAMP Association